TNFSF13B and myasthenia gravis: Although we demonstrated that BAFF levels are higher in AChRAb(+) than MuSK-MG, we were not able to evaluate if there were any differences in BAFF levels depending on CS treatment status in MuSK-MG patients, as their number was small.